trending Market Intelligence /marketintelligence/en/news-insights/trending/y0RrYAM76-vHWt3fbCqogw2 content esgSubNav
In This List

CTI BioPharma adds Syndax COO to board

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


CTI BioPharma adds Syndax COO to board

CTI BioPharma Corp. appointed Michael Metzger as a board member.

Metzger is currently president and COO of Syndax Pharmaceuticals Inc.